TAp73 Acts Via the BHLH Hey2 to Promote Long-term Maintenance of Neural Precursors
Overview
Authors
Affiliations
Increasing evidence suggests that deficits in adult stem cell maintenance cause aberrant tissue repair and premature aging [1]. While the mechanisms regulating stem cell longevity are largely unknown, recent studies have implicated p53 and its family member p63. Both proteins regulate organismal aging [2-4] as well as survival and self-renewal of tissue stem cells [5-9]. Intriguingly, haploinsufficiency for a third family member, p73, causes age-related neurodegeneration [10]. While this phenotype is at least partially due to loss of the ΔNp73 isoform, a potent neuronal prosurvival protein [11-16], a recent study showed that mice lacking the other p73 isoform, TAp73, have perturbations in the hippocampal dentate gyrus [17], a major neurogenic site in the adult brain. These findings, and the link between the p53 family, stem cells, and aging, suggest that TAp73 might play a previously unanticipated role in maintenance of neural stem cells. Here, we have tested this hypothesis and show that TAp73 ensures normal adult neurogenesis by promoting the long-term maintenance of neural stem cells. Moreover, we show that TAp73 does this by transcriptionally regulating the bHLH Hey2, which itself promotes neural precursor maintenance by preventing premature differentiation.
She P, Gao B, Li D, Wu C, Zhu X, He Y Nat Commun. 2025; 16(1):232.
PMID: 39747914 PMC: 11696871. DOI: 10.1038/s41467-024-55557-4.
Alonso-Olivares H, Marques M, Prieto-Colomina A, Lopez-Ferreras L, Martinez-Garcia N, Vazquez-Jimenez A Front Cell Dev Biol. 2024; 12:1464932.
PMID: 39376628 PMC: 11456701. DOI: 10.3389/fcell.2024.1464932.
A novel TAp73-inhibitory compound counteracts stemness features of glioblastoma stem cells.
Villoch-Fernandez J, Martinez-Garcia N, Martin-Lopez M, Maeso-Alonso L, Lopez-Ferreras L, Vazquez-Jimenez A Mol Oncol. 2024; 19(3):852-877.
PMID: 39090849 PMC: 11887682. DOI: 10.1002/1878-0261.13694.
Lithopoulos M, Toussay X, Zhong S, Xu L, Mustafa S, Ouellette J J Clin Invest. 2022; 132(22).
PMID: 36136598 PMC: 9663164. DOI: 10.1172/JCI146095.
Maeso-Alonso L, Lopez-Ferreras L, Marques M, Marin M Front Cell Dev Biol. 2021; 9:716957.
PMID: 34368167 PMC: 8343074. DOI: 10.3389/fcell.2021.716957.